CD4 and cancer: CD4+ Th1 lymphocytes elicit anti-tumor activity, both directly by killing cancer cells after identification of cancer antigens in the context of MHC class I molecules and by releasing cytolytic molecules, and indirectly by activating cytokine release from macrophages.